Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 944317-92-4 | MDL No. : | MFCD15528104 |
Formula : | C10H12BrFO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | CPPYOHQHPFTBON-UHFFFAOYSA-N |
M.W : | 247.10 | Pubchem ID : | 57389499 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.4 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 55.17 |
TPSA : | 9.23 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.1 cm/s |
Log Po/w (iLOGP) : | 2.99 |
Log Po/w (XLOGP3) : | 3.81 |
Log Po/w (WLOGP) : | 4.14 |
Log Po/w (MLOGP) : | 3.87 |
Log Po/w (SILICOS-IT) : | 3.9 |
Consensus Log Po/w : | 3.74 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.98 |
Solubility : | 0.0258 mg/ml ; 0.000104 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.7 |
Solubility : | 0.0495 mg/ml ; 0.0002 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.49 |
Solubility : | 0.00809 mg/ml ; 0.0000327 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 1.8 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
91% | Stage #1: With hydrogen In methanol at 50℃; Inert atmosphere Stage #2: With 1,3-dibromo-5,5-dimethylimidazolidine-2,4-dione In methanol at 40℃; |
Example 4: One pot preparation of 1-bromo-4-fluoro-5-isopropyl-2-methoxybenzene (BrMIP); A 2 L round bottom flask equipped with an magnetic stirrer, an argon inlet and a temperature probe was charged with the commercially available 3M solution of MeMgCI (600 mL, 1.80 mol) in THF. The solution was cooled to -10 °C, and a solution of acetophenone FMAP (170 g, 1 .01 mol) in dry DCM (800 mL) was added dropwise, maintaining the internal temperature below 0 °C. The reaction mixture was then aged at temperature 0 °C for 2 hours. The reaction was quenched with 2M HCI (aq) (900 mL) in a dropwise fashion, maintaining the internal temperature below 20 °C (Caution: very exothermic). The quenched reaction was then aged at 20 °C for 1 hour and the layers were cut. The organic phase was washed with water (1000 mL) and brine (800 mL) and was concentrated under reduced pressure to 220 g. The concentrate contains FMOL and MIPEN in ratio 5:6 estimated by HNMR with total assay of both products ~0.97 mol).The NMR and HPLC showed that the obtained product was substantially free of starting material FMAP, analyzed by HPLC and NMR using identification standard, prepared according to Example 2.A part of above concentrate (94 mL, 73 g of total FMOL/MIPEN, ~0.42 mol) was diluted with MeOH, purged with N2 and 5percent Pd-C (1 .70 g, 0.2 molpercent) was added. The mixture was purged with hydrogen and placed under 3 bar at 50 °C until the reaction was complete based on HPLC analysis. The catalyst was removed by filtration through Celite.(R).. The obtained solution was transferred to a new flask and 1 ,3-dibromo-5,5-dimethylhydantoin (60.7 g, 208 mmol) was added in portions, maintaining the temperature below 40 °C (Caution: exothermic reaction). Eight hours after the completion of the 3-dibromo-5,5-dimethylhydantoin addition, the reaction was complete by HPLC. The reaction was quenched with NaHS03 (5.0 g) and mixed for another 15 minutes. The solution was concentrated to 1/5 of volume and diluted with water (500 mL). The resulting mixture was extracted with petroleum ether (300 mL) and then the organic phase was washed with water (500 mL), 1 M NaOH (aq) (250 mL), water (500 mL) and brine (200 mL). The organic phase was dried over Na2S04, filtered and the solvent removed under reduce pressure to yield BrMIP as a slightly yellow oil (93.03 g, 91 percent according to FMAP). H NMR (CDCI3) δ 1 .22 (d, J = 6.9 Hz, 6H, 2*Me), 3.14 (sept., J = 6.9 Hz, 1 H), 3.85 (s, 3H), 6.60 (d, J = 1 1.8 Hz, 1 H), 7.37 (d, J =8.0 Hz, 1 H). The product BrMIP was substantially free of desmethyl impurity BrMET, analyzed by HPLC and NMR using identification standard, prepared according to Example 2. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
98% | With hydrogen bromide; hydrogen In methanol; water at 20℃; for 0.25 h; Inert atmosphere | The solution of BrMIPEN (1.58 g, 6.4 mmol) and 62percent HBr (0.15 mL) in MeOH (15 mL) was purged with N2 and 5percent Pd-C (0.05 molpercent) was added. The mixture was purged with hydrogen and placed under 60 PSI at room temperature until the reaction was complete based on HPLC analysis (15 min). The catalyst was removed by filtration through celite and the solvent was removed under reduced pressure to yield BrMIP as a colorless oil (1.56 g, 98percent). 1H NMR (CDCl3) δ 1.22 (d, J = 6.9 Hz, 6H), 3.14 (sept., J = 6.9 Hz, 1 H), 3.85 (s, 3H), 6.60 (d, J = 11.8 Hz, 1H), 7.37 (d, J =8.0 Hz, 1H). |
98% | With 5%-palladium/activated carbon; hydrogen bromide; hydrogen In methanol at 20℃; for 0.25 h; Inert atmosphere | Process using Pd/C, 62percent HBr: The solution of BrMIPEN (1.58 g, 6.4 mmol) and 62percent HBr (0.15 mL) in MeOH (15 mL) was purged with N2 and 5percent Pd-C (0.05 molpercent) was added. The mixture was purged with hydrogen and placed under 60 PSI at room temperature until the reaction was complete based on HPLC analysis (15 min). The catalyst was removed by filtration through celite and the solvent was removed under reduced pressure to yield BrMIP as a colorless oil (1 .56 g, 98percent). 1 H NMR (CDCIj) 0 1.22 (d, J = 6.9 Hz, 6H), 3.14 (sept., J = 6.9 Hz, 1 H), 3.85 (s, 3H), 6.60 (d, J = 11.8 Hz, 1 H), 7.37 (d, J =8.0 Hz, 1 H).; Process using Pd/C, thiophene: The solution of BrMIPEN (5.10 g, 19.4 mmol) in MeOH (30 mL) was purged with N2 and thiophene (2.55 mg, 0.05 mol percent) was added, followed by of 5percent Pd-C (0.05 molpercent). The mixture was purged with hydrogen and placed under 60 PSI at room temperature until the reaction was complete based on HPLC analysis. The catalyst was removed by filtration through celite and the solvent was removed under reduced pressure to yield BrMIP as a colorless oil (4.08 g, 85percent). The overall yield for the 4-step process from acetophenone FMAP as described above was up to 82 percent. The product was substantially free of desmethyl impurity, preferably free of 1 -bromo-5-ethyl-4-fluoro-2- methoxy benzene (BrMET) and contains no polysiloxanes as determined by NMR and HPLC. |
88% | With 5%-palladium/activated carbon; hydrogen In tetrahydrofuran at 30 - 35℃; for 12 h; Autoclave; Inert atmosphere | In 1L autoclave, THF 600 g, 1-bromo-4-fluoro-2-methoxy-5-(1-methylvinyl) benzene 239.5.5 g (0.98 mol), and 5percent Pd / C 2.5g were added, the autoclave was closed, nitrogen replacement was carried out 3-4 times, the hydrogen pressure was maintained at 0.5-1.0 MP, and the temperature was maintained between 30-35°C, and reacted for 12 hours. Sampling GC analysis was carried out 1-bromo-4-fluoro-2-methoxy-5- (1-methylvinyl) benzene <0.2percent. After completion of the reaction, the hydrogen in the kettle was replaced with nitrogen, filtered, and Pd / C was recovered. The filtrate was concentrated to recycle THF. The residual material was distilled under reduced pressure, a light yellow oily liquid was collected as 213 g of 1-bromo-4-fluoro-5-isopropyl-2-methoxybenzene. GC content of 99.5percent,Yield 88percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
62% | With 1,1,3,3-Tetramethyldisiloxane; trifluoroacetic acid In 1,2-dichloro-ethane at -20 - -10℃; for 0.25 h; Inert atmosphere | To a flask equipped with a magnetic stirrer, a nitrogen inlet and a temperature probe was charged with tetramethyldisiloxane (17 mL, 0.1 mol) and 1 ,2-dichloroethane (65 mL), cooled to -20°C, and then TFA (10 mL) was added. Then, a solution of carbinol of formula 4 (Scheme 6) (26.3 g, 0.1 mol) in DCE (90 mL) was added dropwise, maintaining the internal temperature below -10 °C. The reaction mixture was aged for 15 min at -10 °C. The reaction mixture was transferred into saturated NaHC03 (120 mL), stirred for 5 min, and the layers were cut. The bottom organic layerwas washed twice with saturated NaHC03 (2x100 mL) and brine (50 mL), dried over Na2SO+ and finally filtered. The solvent was removed under reduced pressure to give brown oil (26.3 g) which was then purified by distillation using 10 cm Vigreux column at 102-104 °C and 5 mbar to yield 5 as a colorless oil (15.2 g, 62 percent). 1H NMR (CDC ) δ 1 .22 (d, J = 6.9 Hz, 6H), 3.14 (sept., J = 6.9 Hz, 1 H), 3.85 (s, 3H), 6.60 (d, J = 11.8 Hz, 1 H), 7.37 (d, J =8.0 Hz, 1 H). The product was contaminated with ~ 5percent of siloxanes. |
[ 450-88-4 ]
1-Bromo-4-fluoro-2-methoxybenzene
Similarity: 0.81
[ 442150-49-4 ]
6-Bromo-1-fluoronaphthalen-2-ol
Similarity: 0.79
[ 452-08-4 ]
2-Bromo-4-fluoro-1-methoxybenzene
Similarity: 0.78
[ 934240-59-2 ]
1-((4-Bromophenoxy)methyl)-2-fluorobenzene
Similarity: 0.77
[ 450-88-4 ]
1-Bromo-4-fluoro-2-methoxybenzene
Similarity: 0.81
[ 442150-49-4 ]
6-Bromo-1-fluoronaphthalen-2-ol
Similarity: 0.79
[ 452-08-4 ]
2-Bromo-4-fluoro-1-methoxybenzene
Similarity: 0.78
[ 934240-59-2 ]
1-((4-Bromophenoxy)methyl)-2-fluorobenzene
Similarity: 0.77
[ 29578-39-0 ]
1-Bromo-3-fluoro-5-methoxybenzene
Similarity: 0.76
[ 450-88-4 ]
1-Bromo-4-fluoro-2-methoxybenzene
Similarity: 0.81
[ 442150-49-4 ]
6-Bromo-1-fluoronaphthalen-2-ol
Similarity: 0.79
[ 452-08-4 ]
2-Bromo-4-fluoro-1-methoxybenzene
Similarity: 0.78
[ 934240-59-2 ]
1-((4-Bromophenoxy)methyl)-2-fluorobenzene
Similarity: 0.77
[ 450-88-4 ]
1-Bromo-4-fluoro-2-methoxybenzene
Similarity: 0.81
[ 452-08-4 ]
2-Bromo-4-fluoro-1-methoxybenzene
Similarity: 0.78
[ 934240-59-2 ]
1-((4-Bromophenoxy)methyl)-2-fluorobenzene
Similarity: 0.77
[ 29578-39-0 ]
1-Bromo-3-fluoro-5-methoxybenzene
Similarity: 0.76
[ 38493-59-3 ]
(3-Bromo-4-methoxyphenyl)methanol
Similarity: 0.76